Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C312
http://purl.obolibrary.org/obo/NCIT_C312
|
|---|---|
| Preferred Name | Bleomycin Sulfate |
| Definitions |
A mixture of the sulfate salts of basic glycopeptide antineoplastic antibiotics isolated from Streptomyces verticillus. Bleomycin sulfate forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A mixture of the sulfate salts of basic glycopeptide antineoplastic antibiotics isolated from Streptomyces verticillus. Bleomycin sulfate forms complexes with iron that reduce molecular oxygen to superoxide and hydroxyl radicals which cause single- and double-stranded breaks in DNA; these reactive oxygen species also induce lipid peroxidation, carbohydrate oxidation, and alterations in prostaglandin synthesis and degradation. |
|---|---|
| prefLabel | Bleomycin Sulfate
|
| label | Bleomycin Sulfate
|
| CHEBI_ID | CHEBI:34582
|
| PDQ_Closed_Trial_Search_ID | 39139
|
| code | C312
|
| prefixIRI | NCIT:C312
|
| in_subset |
See more
See less
|
| Display_Name | Bleomycin Sulfate
|
| Preferred_Name | Bleomycin Sulfate
|
| FDA_UNII_Code | 7DP3NTV15T
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Bleomycin Sulfate
|
| CAS_Registry | 9041-93-4
|
| NCI_Drug_Dictionary_ID | 39139
|
| Legacy Concept Name | Bleomycin_Sulphate
|
| Has_Free_Acid_Or_Base_Form | |
| type | |
| ALT_DEFINITION | A drug that is used to treat many types of cancer and is being studied in the treatment of other types of cancer. It comes from the bacterium Streptomyces verticillus. Blenoxane that damages DNA and may kill cancer cells. It is a type of antineoplastic antibiotic.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 39139
|
| Accepted_Therapeutic_Use_For | Squamous cell carcinomas of the head and neck; penis; cervix and vulva; Hodgkins and; non-Hodgkins lymphoma; testicular embryonal cell and ovarian carcinoma; chorio- and teratocarcinoma; malignant pleural effusion; melanoma; sarcoma; ovary germ cell tumor
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Antibiotic
|
| UMLS_CUI | C0005739
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |